Table 5.
Correlation between PSQI score with age, anthropometric measurements, body composition parameters, and inflammatory biomarker of the study at baseline and after 31 days of active stage of VLCKD
| n = 324 | Baseline | Day 31 of VLCKD | ||
|---|---|---|---|---|
| Parameters | r | *p-value | r | *p-value |
| Age (years) | − 0.039 | 0.487 | − 0.004 | 0.945 |
| Weight (kg) | 0.756 | < 0.001 | 0.641 | < 0.001 |
| BMI (kg/m2) | 0.677 | < 0.001 | 0.615 | < 0.001 |
| WC (cm) | 0.541 | < 0.001 | 0.498 | < 0.001 |
| BIA parameters | ||||
| R (Ω) | 0.013 | 0.821 | 0.071 | 0.200 |
| Xc (Ω) | − 0.262 | < 0.001 | 0.001 | 0.996 |
| FFM (kg) | 0.282 | < 0.001 | 0.229 | < 0.001 |
| FM (kg) | 0.808 | < 0.001 | 0.699 | < 0.001 |
| FFM (%) | − 0.734 | < 0.001 | − 0.631 | < 0.001 |
| FM (%) | 0.734 | < 0.001 | 0.631 | < 0.001 |
| PhA (°) | − 0.355 | < 0.001 | − 0.079 | 0.154 |
| ahs-CRP levels (mg/L) | 0.269 | < 0.001 | 0.141 | 0.023 |
PSQI Pittsburgh Sleep Quality Index, SD standard deviation, VLCKD very low-calorie ketogenic diet, BMI body mass index, WC waist circumference, R resistance, Xc reactance, FFM free fat mass, FM fat mass, PhA phase angle, hs-CRP high-sensitivity C-reactive protein
*A p value in bold type denotes a significant difference (p < 0.05).
ahs-CRP levels were evaluated in a subgroup of 263 women